comparing risk among disparate categories, and its recommendations, with input from FDA, will help to identify a framework for making advances in FDA management processes and decisions.
The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Letter Report ."
Letter Report on the Development of a Model for Ranking FDA Product Categories on the Basis of Health Risks . Washington, DC: The National Academies Press,
Please select a format: